$ELV Q2 '25 Earnings Results & Recap
Elevance Health reported Q2 '25 adjusted EPS of $8.84, below estimates of $8.92, which was consistent with expectations, and revenue of $49.42B. The firm revised its full-year 2025 adjusted EPS guidance to approximately $30 due to elevated medical costs and slower Medicaid rate alignment.